Biochemical indicators of cardiac and renal function in a healthy elderly population

被引:82
作者
Johnston, N
Jernberg, T
Lindahl, B
Lindbäck, J
Stridsberg, M
Larsson, A
Venge, P
Wallentin, L
机构
[1] Univ Uppsala Hosp, Dept Med Sci, S-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Uppsala Res Ctr, S-75185 Uppsala, Sweden
关键词
NT-proBNP; cystatin C; cardiac and renal function; healthy elderly population;
D O I
10.1016/j.clinbiochem.2003.11.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To examine the distributions of NT-proBNP and cystatin C and their relation to age, gender, and other physiological factors in an apparently healthy elderly population. Method: NT-proBNP and cystatin C were analyzed in 407 and 408 healthy individuals, median age: 65 (range 40-76). Results: Increasing age, female gender and CRP were independently associated to higher NT-proBNP levels. Age, body mass index, and CRP level were independently associated to the cystatin C level. In women and men, less than or equal to65 years, the 97.5th percentile value for NT-proBNP was 268 ng/l and 184 ng/l, in those older, 391 ng/l and 269 ng/l. For those less than or equal to65 years the 97.5th percentile value for cystatin C was 1.12 mg/l, and for those older 1.21 mg/l. Conclusion: In a healthy elderly population, NT-proBNP is influenced by age and gender, whereas cystatin C is influenced by age but not by gender. Both markers seem to be associated to the CRP level. (C) 2003 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:210 / 216
页数:7
相关论文
共 41 条
  • [31] Plasma brain natriuretic peptide concentration: Impact of age and gender
    Redfield, MM
    Rodeheffer, RJ
    Jacobsen, SJ
    Mahoney, DW
    Bailey, KR
    Burnett, JC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) : 976 - 982
  • [32] Guidelines for the diagnosis and treatment of chronic heart failure
    Remme, WJ
    Swedberg, K
    [J]. EUROPEAN HEART JOURNAL, 2001, 22 (17) : 1527 - 1560
  • [33] Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin - Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction
    Richards, AM
    Doughty, R
    Nicholls, MG
    MacMahon, S
    Sharpe, N
    Murphy, J
    Espiner, EA
    Frampton, C
    Yandle, TG
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) : 1781 - 1787
  • [34] Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal?
    Sayama, H
    Nakamura, Y
    Saito, N
    Kinoshita, M
    [J]. CORONARY ARTERY DISEASE, 1999, 10 (07) : 537 - 540
  • [35] Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction
    Stanek, B
    Frey, B
    Hülsmann, M
    Berger, R
    Sturm, B
    Strametz-Juranek, J
    Bergler-Klein, J
    Moser, P
    Bojic, A
    Hartter, E
    Pacher, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) : 436 - 442
  • [36] Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population
    Talwar, S
    Squire, IB
    Davies, JE
    Barnett, DB
    Ng, LL
    [J]. EUROPEAN HEART JOURNAL, 1999, 20 (23) : 1736 - 1744
  • [37] Mechanical load-induced alterations in B-type natriuretic peptide gene expression
    Tokola, H
    Hautala, N
    Marttila, M
    Magga, J
    Pikkarainen, S
    Kerkelä, R
    Vuolteenaho, O
    Ruskoaho, H
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2001, 79 (08) : 646 - 653
  • [38] Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
    Troughton, RW
    Frampton, CM
    Yandle, TG
    Espiner, EA
    Nicholls, MG
    Richards, AM
    [J]. LANCET, 2000, 355 (9210) : 1126 - 1130
  • [39] Uhlmann EJ, 2001, CLIN CHEM, V47, P2031
  • [40] Wallentin L, 1999, LANCET, V354, P708